Andrew Obenshain
Overview
Andrew Obenshain received an average of $6M in total compensation, including $565K in salary, at bluebird bio between 2021 and 2022.
Source: SEC filings on April 28, 2023 and May 2, 2022.
Related executives
We found 12 more executives who work or worked at bluebird bio.
Jason Cole
bluebird bio
Chief Strategy & Financial Officer former
Richard Colvin
bluebird bio
Chief Medical Officer
Thomas Klima
bluebird bio
Chief Commercial and Operating Officer
Nick Leschly
bluebird bio
Chief Executive Officer
Gina Consylman
bluebird bio
Chief Financial Officer
William Baird
bluebird bio
Chief Financial Officer
Philip Gregory
bluebird bio
Chief Scientific Officer
Jeffrey Walsh
bluebird bio